The development of life-saving drugs is fraught with both opportunity and risk. Modern drug development requires companies to be exceedingly nimble, balancing high R&D costs, elevated levels of competitive risk, the management of lengthy product-development life cycles, and an arduous global regulatory environment. Biotech companies need to partner with law firms who understand how to navigate them through these challenges toward a strong market position.

Haug Partners’ fully-integrated Biotechnology team includes trial attorneys, registered patent agents, regulatory and compliance specialists, and in-house scientific advisors with advanced degrees in technical fields, coupled with hands-on industry experience. Our attorneys draw from their legal and scientific expertise to provide comprehensive solutions for our clients in the biotech industry.

Our industry experience is broad: we have worked with both innovator and follow-on drugs, and are able to strategically counsel clients from both perspectives. Our nationally-renowned litigators contribute to prominent Hatch-Waxman and antitrust practices that help our clients manage competitive risk to their advantage, and our FDA regulatory attorneys provide advice on compliance and enforcement, pathways to approval, and product development and life-cycle management issues. Haug Partners’ unique cross-functional biotechnology, biopharmaceutical, patent litigation and prosecution, FDA, and antitrust practices enable our Biotechnology team to provide seamless, interdisciplinary counseling and representation across all phases of a product’s life-cycle.